Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Zymeworks Inc.
  6. News
  7. Summary
    ZYME   CA98985W1023

ZYMEWORKS INC.

(ZYME)
  Report
Delayed Nyse  -  05/20 04:00:02 pm EDT
5.990 USD   +2.92%
04:26pZYMEWORKS' : Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal - Form 8-K
PU
09:56aZymeworks Board Rejects All Blue Falcons Takeover Bid for $10.50 Per Share
MT
09:16aZymeworks' Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ZYMEWORKS INC.
04:26pZYMEWORKS' : Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal - Fo..
PU
09:56aZymeworks Board Rejects All Blue Falcons Takeover Bid for $10.50 Per Share
MT
09:16aZymeworks' Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
BU
05/09Citigroup Lowers Zymeworks Price Target to $28 From $30, Buy Rating Kept
MT
05/05Guggenheim Upgrades Zymeworks to Buy From Neutral; Price Target is $14
MT
05/04TRANSCRIPT : Zymeworks Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
BU
05/04Earnings Flash (ZYME) ZYMEWORKS Posts Q1 Loss $-1.17, vs. Street Est of $-0.76
MT
05/04Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03All blue capital announces leadership to support proposed acquisition of zymeworks, inc..
PR
05/03Alan Barge Would Serve on Zymeworks Inc.'s Board
CI
05/02Zymeworks Announces Participation in Upcoming Investor Conferences
BU
04/29ZYMEWORKS : Confirms Receipt of Unsolicited, Non-Binding Proposal from All Blue Falcons - ..
PU
04/29Thinking about buying stock in Finch Therapeutics, Zymeworks, DiDi Global, Bilibili, or..
PR
04/29Zymeworks Receives Unsolicited Purchase Offer from All Blue Falcons; Shares Rise After-..
MT
More most relevant news
All news about ZYMEWORKS INC.
04:26pZYMEWORKS' : Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal - Fo..
PU
09:56aZymeworks Board Rejects All Blue Falcons Takeover Bid for $10.50 Per Share
MT
09:16aZymeworks' Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
BU
05/09Citigroup Lowers Zymeworks Price Target to $28 From $30, Buy Rating Kept
MT
05/05Guggenheim Upgrades Zymeworks to Buy From Neutral; Price Target is $14
MT
05/04TRANSCRIPT : Zymeworks Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
BU
05/04Earnings Flash (ZYME) ZYMEWORKS Posts Q1 Loss $-1.17, vs. Street Est of $-0.76
MT
05/04ZYMEWORKS INC. Management's Discussion and Analysis of Financial Condition and Results..
AQ
05/04Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
More news
News in other languages on ZYMEWORKS INC.
09:56aLe conseil d'administration de Zymeworks rejette l'offre publique d'achat de All Blue F..
05/04Zymeworks Inc. annonce ses résultats pour le premier trimestre terminé le 31 mars 2022
05/03Alan Barge siégera au conseil d'administration de Zymeworks Inc.
05/03L'ancien responsable de l'oncologie chez AstraZeneca aide All Blue dans son offre publi..
04/29MISE À JOUR SECTORIELLE : Les actions du secteur de la santé sont martelées par la baisse ..
04/29MISE À JOUR SECTORIELLE : Les actions du secteur de la santé ont baissé vendredi mais ont ..
04/29Zymeworks reçoit une offre d'achat non sollicitée de la part de All Blue Falcons ; les ..
04/28All Blue Capital fait une offre de 773 millions de dollars pour Zymeworks
04/28Zymeworks achève le recrutement pour un essai sur le cancer du tractus biliaire
04/28Zymeworks Inc. annonce le recrutement du dernier patient de l'étude de base sur le zani..
More news
Analyst Recommendations on ZYMEWORKS INC.
05/09Citigroup Lowers Zymeworks Price Target to $28 From $30, Buy Rating Kept
MT
05/05Guggenheim Upgrades Zymeworks to Buy From Neutral; Price Target is $14
MT
03/15Evercore ISI Starts Zymeworks at Outperform With $15 Price Target
MT
02/25Stifel Adjusts Price Target for Zymeworks to $24 From $51, Maintains Buy Rating
MT
02/09Wells Fargo Adjusts Zymeworks' Price Target to $45 From $56, Reiterates Overweight Rati..
MT
More recommendations
Press releases
04:27pZYMEWORKS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04:26pZYMEWORKS' : Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal - Fo..
PU
09:16aZymeworks' Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
BU
05/04Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
BU
05/04ZYMEWORKS INC. Management's Discussion and Analysis of Financial Condition and Results..
AQ
More press releases
Upcoming event on ZYMEWORKS INC.
05/24/22H.C. Wainwright Global Investment Conference
Upcoming sector events
07/27/22VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected)
07/27/22GILEAD SCIENCES, INC. : Interim 2022 Earnings Release (Projected)
08/04/22REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release (Projected)
08/08/22BIONTECH SE : Interim 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs